Literature DB >> 31724564

Ischemic liver lesions mimicking neoplasm in a patient with severe chronic mesenteric ischemia.

Bernardo C Mendes1, Gustavo S Oderich1, Thanila A Macedo2, Roger K Moreira3.   

Abstract

Chronic mesenteric ischemia most frequently presents with abdominal pain, weight loss, and food fear. Ischemic involvement of the liver is infrequent because of the dual blood supply via the portal vein and hepatic artery. Hepatic infarction has been associated with embolization, thrombosis, arterial injury, prothrombotic states, and impairment of portal venous flow. We report a patient with chronic mesenteric ischemia and severe mesenteric arterial disease who presented with large liver masses suspicious for neoplasm. Tissue samples from two hepatic biopsies confirmed ischemic lesions. After open surgical mesenteric revascularization, the patient had complete symptom improvement and nearly complete regression of the liver lesions.
© 2015 The Authors.

Entities:  

Year:  2015        PMID: 31724564      PMCID: PMC6849893          DOI: 10.1016/j.jvsc.2015.03.020

Source DB:  PubMed          Journal:  J Vasc Surg Cases        ISSN: 2352-667X


Chronic mesenteric ischemia (CMI) most often presents with abdominal pain, weight loss, and food fear. Because of extensive collaterals, most patients with symptoms of CMI have stenosis or occlusion of at least two of the three mesenteric arteries.2, 3 Diagnostic imaging is recommended to confirm the diagnosis, plan an intervention, and evaluate other potential causes of abdominal pain such as malignancy, inflammatory bowel disease, or motility disorders. Liver infarction as a presentation of CMI has not been described, possibly due to dual blood supply via the hepatic artery and portal vein. We report a patient who presented with CMI associated with severe three-vessel mesenteric artery disease and two large ischemic liver lesions. The patient consented with the operation and with publication of this manuscript.

Case report

A 76-year-old man presented with an 8-month history of postprandial abdominal pain, food fear, and 40-pound weight loss. The patient reported significant worsening of abdominal pain over 5 weeks requiring total parenteral nutrition due to inability to have any oral intake. His medical history was notable for prior attempted mesenteric stenting at another institution 2 months before presentation, which was unsuccessful, coronary artery disease, coronary artery bypass grafting, peripheral artery disease, bilateral iliac artery stents, and Barrett esophagus. Computed tomography angiography (CTA) demonstrated heavy calcification and occlusion of the celiac artery, long-segment occlusion of the superior mesenteric artery (SMA), and a small, diseased inferior mesenteric artery (Fig 1). Both internal iliac arteries were occluded with distal collateral reconstitution.
Fig 1

A, Computed tomography angiography (CTA) of the abdominal aorta demonstrates a highly calcified aorta and bilateral iliac vessels, with occlusion of the celiac axis and a long segment of the superior mesenteric artery (SMA). B, Schematic drawing and (C) intraoperative photograph show a 14-mm × 7-mm bifurcated polyester graft originating from the supraceliac aorta, with one limb anastomosed end-to-side to the common hepatic artery and one limb tunnelled retropancreatic and anastomosed end-to-side to the distal SMA.

A, Computed tomography angiography (CTA) of the abdominal aorta demonstrates a highly calcified aorta and bilateral iliac vessels, with occlusion of the celiac axis and a long segment of the superior mesenteric artery (SMA). B, Schematic drawing and (C) intraoperative photograph show a 14-mm × 7-mm bifurcated polyester graft originating from the supraceliac aorta, with one limb anastomosed end-to-side to the common hepatic artery and one limb tunnelled retropancreatic and anastomosed end-to-side to the distal SMA. There were two large heterogeneous liver lesions, including a 6-cm mass in the inferior aspect of the right hepatic lobe (segment VI) and 4-cm poorly marginated mass with enhancing and cystic components in the periphery of the right hepatic lobe (segment VIII). Both lesions had associated segmental bile duct dilatation (Fig 2). There was thickening of the ascending colon wall. Concentrations of serum alanine and aspartate aminotransferases, alkaline phosphatase, and albumin, and prothrombin time were within normal limits.
Fig 2

A, Portal venous-phase computed tomography angiography (CTA) demonstrates two hypodense, hepatic lesions measuring 4 cm and presenting with enhancing and cystic components in the segment VIII, with associated segmental bile duct dilation, and a nonhomogeneous mass measuring 6 cm in the segment VI. B, Postoperative CTA demonstrates nearly complete resolution of hepatic lesions after hepatic and mesenteric revascularization. C, Colon biopsy specimen shows colonic mucosa with focal areas of crypt “withering” and associated hyalinization of the lamina propria, consistent with ischemic-type injury. A focus of acute inflammation (crypt abscess) is also present (hematoxylin and eosin, original magnification ×400. Needle core biopsy sample shows extensive coagulative necrosis of the liver parenchyma with surrounding fibrous tissue and minimal reactive inflammatory infiltrate, without evidence of malignancy (hematoxylin and eosin, original magnification ×200).

A, Portal venous-phase computed tomography angiography (CTA) demonstrates two hypodense, hepatic lesions measuring 4 cm and presenting with enhancing and cystic components in the segment VIII, with associated segmental bile duct dilation, and a nonhomogeneous mass measuring 6 cm in the segment VI. B, Postoperative CTA demonstrates nearly complete resolution of hepatic lesions after hepatic and mesenteric revascularization. C, Colon biopsy specimen shows colonic mucosa with focal areas of crypt “withering” and associated hyalinization of the lamina propria, consistent with ischemic-type injury. A focus of acute inflammation (crypt abscess) is also present (hematoxylin and eosin, original magnification ×400. Needle core biopsy sample shows extensive coagulative necrosis of the liver parenchyma with surrounding fibrous tissue and minimal reactive inflammatory infiltrate, without evidence of malignancy (hematoxylin and eosin, original magnification ×200). A gastroenterology consultation was obtained to evaluate possible metastatic malignant disease. An esophagogastroduodenoscopy demonstrated Barrett esophagus, with no evidence of malignancy. A colonoscopy was negative for neoplasm but suggestive of ischemic-type injury. Carcinoembryonic antigen was minimally elevated at 4.9 ng/mL. A specimen obtained from an ultrasound-guided biopsy of the liver masses demonstrated necrotic liver tissue that could potentially correspond to malignancy, with no definite neoplasia identified. A specimen from a repeat biopsy in a different lesion showed isolated hepatic necrosis with no evidence of malignancy (Fig 2). These findings led to a proposed diagnosis of hepatic infarction secondary to chronic atherosclerotic mesenteric ischemia, and open surgical mesenteric revascularization was recommended. A midline transperitoneal abdominal exploration revealed no evidence of palpable abdominal masses involving the liver, small intestine, colon, or peritoneum. There was extensive calcification of the infrarenal aorta, iliac arteries, and proximal SMA. A bifurcated supraceliac aorta-to-common hepatic artery and SMA graft was performed using a 14-mm × 7-mm polyester graft. The left side limb was tunneled in a retropancreatic position and anastomosed end-to-side to the distal SMA, and the right limb was anastomosed end-to-side to the common hepatic artery. Intraoperative ultrasound imaging revealed a widely patent graft with no evidence of technical defects. The patient had an uneventful postoperative course, with adequate tolerance to oral diet, discontinuation of the total parenteral nutrition, and hospital discharge on postoperative day 8. A CTA repeated 4 days after the operation demonstrated widely patent bypass limbs and a decrease in the size of both ischemic lesions. At 12 months, the patient had gained 40 pounds and was free of recurrent symptoms. Repeat CTA demonstrated a widely patent bifurcated graft and nearly complete regression of both hepatic lesions, thus confirming its ischemic nature (Fig 2, B).

Discussion

CMI rarely involves solid organs, such as the liver or spleen, unless there is distal embolization from a proximal source. Hepatic infarction has been associated with surgical or interventional procedures, liver transplantation, arterial embolization, and prothrombotic states.5, 6 The vascular anatomy of the upper abdomen contains extensive collaterals that compensate chronic occlusion of the celiac axis or proximal segments of the hepatic artery, including the left gastric, gastroduodenal, pancreatoduodenal, and parietal vessels such as the intercostal and phrenic arteries.4, 7 Because of its dual blood supply via the hepatic artery and portal vein and the extensive collateral network between the mesenteric arteries, the liver is resistant to chronic ischemic injury. Provided there is normal portal venous flow, hepatic necrosis is uncommon with isolated hepatic artery occlusion, with the exception of bile duct and gallbladder ischemia that occurs with injury or thrombosis of the right hepatic artery. Isolated portal venous obstruction or thrombosis with normal arterial inflow will rarely lead to hepatic necrosis.4, 9 In the patient presented here, there was extensive arterial disease involving the celiac axis, SMA, and inferior mesenteric artery, with no evidence of any abnormality affecting the portal venous system. The hepatic infarction was likely due to significant ischemia from the poor collateral arterial network, although distal arterial embolization could not be ruled out as a potential cause. The radiologic appearance of hepatic infarction varies widely. Prior descriptions include peripheral wedge-shaped to central, round, nonhomogeneous lesions, with or without bile duct necrosis.5, 10, 11 Holbert et al reviewed CT studies from 18 patients who had 55 specimen-proven ischemic hepatic lesions. In 83% of the patients, hepatic infarction resulted from complications of liver transplantation. At presentation, all hepatic lesions were associated with lower attenuation in unenhanced and enhanced studies compared with surrounding hepatic parenchyma. Round or oval lesions were more common, but wedge-shaped lesions with bile duct necrosis occurred in few patients. One of four wedge-shaped lesions evolved into round lesions, which are more difficult to differentiate from abscess or metastatic disease on the basis of CT appearance. In these cases, a biopsy specimen was recommended to rule out or confirm malignancy. The authors concluded that hepatic infarction can present with varied appearance reflecting the evolutionary process of ischemic injury. In the presented case, hepatic lesions had a round-oval pattern rather than wedge-shaped, which led to needle aspiration due to the indeterminate appearance and malignant potential. The importance of cross-sectional imaging in the evaluation of patients with CMI cannot be overemphasized. Because symptoms are nonspecific, other causes of chronic abdominal pain and weight loss should be evaluated, including malignant and inflammatory bowel disease. Imaging is useful not only to confirm mesenteric artery disease but also to plan mesenteric revascularization. In this case, the extensive involvement of the SMA by long-segment occlusion and calcification rendered percutaneous stenting technically more difficult and prone to a suboptimal result. Recanalization would require stenting of at least 7 cm of SMA and re-entrance in the very distal SMA. Although stenting is possible in select cases of long occlusion, these patients have higher rates of restenosis and late failure. Therefore, we opted for an open surgical revascularization. Albeit rare, this case should raise the awareness that liver lesions in patients with classic symptoms of CMI can be associated with ischemia. Although angioplasty and stenting is the first treatment option in most patients with CMI,12, 13 a subset of patients will still benefit from conventional open revascularization due to extensive occlusion, failed stents, or unusual etiology.2, 14, 15 This case illustrates an example of long-segment occlusion of the SMA and celiac artery with heavy calcification with previous failed attempted endovascular revascularization, rendering open revascularization a reasonable option. The choice of two-vessel reconstruction is controversial but made logical sense in this patient with ischemic liver lesions revascularization of the hepatic artery.1, 16

Conclusions

This case illustrates an unusual clinical presentation of CMI with ischemic damage to the liver mimicking neoplasm. The long-segment occlusion and heavy calcification of the mesenteric arteries rendered this patient not an ideal candidate for an endovascular intervention. Open revascularization in these patients remains a valuable option and is associated with excellent long-term symptom improvement and high patency rates.
  16 in total

1.  Retrospective study of 23 cases of hepatic infarction: CT findings and pathological correlations.

Authors:  S Giovine; A Pinto; S Crispano; F Lassandro; L Romano
Journal:  Radiol Med       Date:  2006-02       Impact factor: 3.469

2.  Open surgical treatment for chronic mesenteric ischemia in the endovascular era: when it is necessary and what is the preferred technique?

Authors:  Gustavo S Oderich; Peter Gloviczki; Thomas C Bower
Journal:  Semin Vasc Surg       Date:  2010-03       Impact factor: 1.000

3.  Mesenteric artery complications during angioplasty and stent placement for atherosclerotic chronic mesenteric ischemia.

Authors:  Gustavo S Oderich; Tiziano Tallarita; Peter Gloviczki; Audra A Duncan; Manju Kalra; Sanjay Misra; Stephen Cha; Thomas C Bower
Journal:  J Vasc Surg       Date:  2012-02-08       Impact factor: 4.268

4.  Eleven cases of postoperative hepatic infarction following pancreato-biliary surgery.

Authors:  Fumihiko Miura; Takehide Asano; Hodaka Amano; Masahiro Yoshida; Naoyuki Toyota; Keita Wada; Kenichoro Kato; Koichi Hayano; Susumu Kadowaki; Makoto Shibuya; Sawako Maeno; Tadahiro Takada; Tomoaki Eguchi
Journal:  J Gastrointest Surg       Date:  2010-02       Impact factor: 3.452

5.  Open versus endovascular revascularization for chronic mesenteric ischemia: risk-stratified outcomes.

Authors:  Gustavo S Oderich; Thomas C Bower; Timothy M Sullivan; Haraldur Bjarnason; Stephen Cha; Peter Gloviczki
Journal:  J Vasc Surg       Date:  2009-06       Impact factor: 4.268

6.  Mesenteric revascularization: management and outcomes in the United States, 1988-2006.

Authors:  Marc L Schermerhorn; Kristina A Giles; Allen D Hamdan; Mark C Wyers; Frank B Pomposelli
Journal:  J Vasc Surg       Date:  2009-04-16       Impact factor: 4.268

7.  Hepatic infarction secondary to arterial insufficiency in native livers: CT findings in 10 patients.

Authors:  G S Smith; B A Birnbaum; J E Jacobs
Journal:  Radiology       Date:  1998-07       Impact factor: 11.105

8.  Extrahepatic arterial supply to the liver: observation with a unified CT and angiography system during temporary balloon occlusion of the proper hepatic artery.

Authors:  Y Takeuchi; Y Arai; Y Inaba; K Ohno; T Maeda; Y Itai
Journal:  Radiology       Date:  1998-10       Impact factor: 11.105

9.  Hepatic infarction caused by arterial insufficiency: spectrum and evolution of CT findings.

Authors:  B L Holbert; R L Baron; G D Dodd
Journal:  AJR Am J Roentgenol       Date:  1996-04       Impact factor: 3.959

10.  Reinterventions for stent restenosis in patients treated for atherosclerotic mesenteric artery disease.

Authors:  Tiziano Tallarita; Gustavo S Oderich; Thanila A Macedo; Peter Gloviczki; Sanjay Misra; Audra A Duncan; Manju Kalra; Thomas C Bower
Journal:  J Vasc Surg       Date:  2011-10-02       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.